Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Data Reporting and Recording
Hepatic Portal System
Types of Reports I: Hands-off Report
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Types of Reports II: Incident or Occurrence Report
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 27, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Ana Gómez Outomuro1, Miguel Fraile2, María Torner3
1Digestivo, Hospital Universitario Central de Asturias, España.
Immunosuppressed patients may show delayed hepatitis C virus (HCV) antibody development. Early HCV-RNA testing is crucial for timely diagnosis and treatment in these individuals.
Area of Science:
Background: